BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 10089876)

  • 1. Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT.
    Crabtree GR
    Cell; 1999 Mar; 96(5):611-4. PubMed ID: 10089876
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypertrophy of the heart: calcineurin-NFAT pathway may be a new therapeutic target].
    Zhang YJ; Dong LF; Wang YL
    Yao Xue Xue Bao; 2006 Oct; 41(10):913-6. PubMed ID: 17184105
    [No Abstract]   [Full Text] [Related]  

  • 3. [Multiple actions of tacrolimus and cyclosporin A as specific inhibitors of calcineurin].
    Tamura K
    Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1118-30. PubMed ID: 9655970
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
    Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcineurin and beyond: cardiac hypertrophic signaling.
    Molkentin JD
    Circ Res; 2000 Oct; 87(9):731-8. PubMed ID: 11055975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manipulating immune responses with immunosuppressive agents that target NFAT.
    Kiani A; Rao A; Aramburu J
    Immunity; 2000 Apr; 12(4):359-72. PubMed ID: 10795734
    [No Abstract]   [Full Text] [Related]  

  • 7. Signaling path may lead to better heart-failure therapies.
    Barinaga M
    Science; 1998 Apr; 280(5362):383. PubMed ID: 9575084
    [No Abstract]   [Full Text] [Related]  

  • 8. Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin-sensitive intramolecular interaction.
    Beals CR; Clipstone NA; Ho SN; Crabtree GR
    Genes Dev; 1997 Apr; 11(7):824-34. PubMed ID: 9106655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcineurin-NFAT signaling, together with GABP and peroxisome PGC-1{alpha}, drives utrophin gene expression at the neuromuscular junction.
    Angus LM; Chakkalakal JV; Méjat A; Eibl JK; Bélanger G; Megeney LA; Chin ER; Schaeffer L; Michel RN; Jasmin BJ
    Am J Physiol Cell Physiol; 2005 Oct; 289(4):C908-17. PubMed ID: 15930144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid shuttling of NF-AT in discrimination of Ca2+ signals and immunosuppression.
    Timmerman LA; Clipstone NA; Ho SN; Northrop JP; Crabtree GR
    Nature; 1996 Oct; 383(6603):837-40. PubMed ID: 8893011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunosuppressive drugs and calcineurin].
    Masugi T; Otsuka K
    Tanpakushitsu Kakusan Koso; 1998 Sep; 43(12 Suppl):1739-43. PubMed ID: 9788176
    [No Abstract]   [Full Text] [Related]  

  • 12. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.
    Molkentin JD; Lu JR; Antos CL; Markham B; Richardson J; Robbins J; Grant SR; Olson EN
    Cell; 1998 Apr; 93(2):215-28. PubMed ID: 9568714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-dependent activation of nuclear factor regulated by interleukin 3/adenovirus E4 promoter-binding protein gene expression by calcineurin/nuclear factor of activated T cells and calcium/calmodulin-dependent protein kinase signaling.
    Nishimura Y; Tanaka T
    J Biol Chem; 2001 Jun; 276(23):19921-8. PubMed ID: 11262393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcineurin mutants render T lymphocytes resistant to cyclosporin A.
    Zhu D; Cardenas ME; Heitman J
    Mol Pharmacol; 1996 Sep; 50(3):506-11. PubMed ID: 8794888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of the calcineurin/NFAT pathway.
    Martínez-Martínez S; Redondo JM
    Curr Med Chem; 2004 Apr; 11(8):997-1007. PubMed ID: 15078162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of nuclear factor of activated T-cells in calcineurin-mediated cardiomyocyte hypertrophy.
    van Rooij E; Doevendans PA; de Theije CC; Babiker FA; Molkentin JD; de Windt LJ
    J Biol Chem; 2002 Dec; 277(50):48617-26. PubMed ID: 12226086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A.
    Al-Daraji WI; Grant KR; Ryan K; Saxton A; Reynolds NJ
    J Invest Dermatol; 2002 May; 118(5):779-88. PubMed ID: 11982754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB.
    Tsatsanis C; Patriotis C; Tsichlis PN
    Oncogene; 1998 Nov; 17(20):2609-18. PubMed ID: 9840924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcineurin and the biological effect of cyclosporine and tacrolimus.
    Halloran PF; Kung L; Noujaim J
    Transplant Proc; 1998 Aug; 30(5):2167-70. PubMed ID: 9723430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin a inhibits calcineurin/nuclear factor of activated T-cells signaling and induces apoptosis in retinoblastoma cells.
    Eckstein LA; Van Quill KR; Bui SK; Uusitalo MS; O'Brien JM
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):782-90. PubMed ID: 15728531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.